Search

everythinglearnresearchcommunity

for

Search:↓

Mesenchymal stem cells could help treat radiation-induced bladder damage but more research is needed to overcome current limitations.

The symposium highlighted the importance of genetics in understanding and treating complex skin diseases.

Psoriasis may be chronic because it lacks certain immune system controls that prevent overreaction.

Innate lymphoid cells help control skin bacteria by regulating sebaceous glands.

Intestinal intraepithelial lymphocytes are crucial for gut immunity and maintaining the mucosal barrier.

New methods to improve the healing abilities of mesenchymal stem cells for disease treatment are promising but need more research.

Different sPLA2 enzymes affect immunity, skin and hair health, reproduction, and may be potential targets for therapy.

Oleoylethanolamide (OEA) safely boosts fat production in skin cells and may help treat dry skin and reduce inflammation.

The role of γδT-cells in causing alopecia areata remains unclear.

People with atopic dermatitis have more CD4+ T cells that respond to a certain bacterial lipid, which may play a role in the skin condition's inflammation.

Ginsenoside Rd may help improve skin aging by increasing collagen in the skin.

Removing STAT5 from 3D-cultured human skin cells reduces their ability to grow hair.

Tildrakizumab showed limited effectiveness in treating chronic alopecia areata in a small group of patients.

PPAR agonists show promise for skin conditions but need more research before being a main treatment.

Type I interferons play a key role in the development of various skin diseases.

New treatments and diagnostic methods for various animal skin conditions showed promising results.

Eating less sugar, milk, and saturated fats and more vegetables and fish may help treat and prevent acne.

Targeting CD200 could be a new treatment for rheumatoid arthritis.

The conclusion is that understanding the complex relationship between allergies, autoimmunity, and psychological factors is key to treating skin disorders with itching.

CD2 might be a new treatment target for patchy alopecia areata.

Pantethine may boost the immune system's ability to fight sarcoma.

Melanocytes produce melanin; their defects cause vitiligo and hair graying, with treatments available for vitiligo.

Alopecia areata is likely an autoimmune disease with unclear triggers, involving various immune cells and molecules, and currently has no cure.

The conclusion is that Treg-targeted therapies have potential, but more knowledge of Treg biology is needed for effective treatments, including for cancer.

Skin's Regulatory T cells are crucial for maintaining skin health and could be targeted to treat immune-related skin diseases and cancer.

Animal models have helped understand hair loss from alopecia areata and find new treatments.

Dupilumab is being tested for many new skin, respiratory, and gastrointestinal conditions.

Low vitamin D might be linked to certain types of hair loss, and supplements could help, but more research is needed.

Thyroid diseases may contribute to autoimmune skin diseases, and more research is needed on their relationship.